A urologist evaluating recurrent urinary tract infections will typically start with a structured diagnostic workup and then move through a tiered set of treatments, beginning with behavioral and non-antibiotic strategies and escalating to antibiotic prophylaxis, bladder instillations, or even minor surgical procedures depending on what the evaluation reveals. Recurrent UTIs are generally defined as two culture-confirmed infections within six months or three within a year, and the urologist’s role is to figure out whether something anatomical or functional is driving the pattern and to break the cycle with the least amount of antibiotic exposure possible.
The Initial Evaluation
The first thing a urologist does is confirm that you actually have recurrent UTIs and not something mimicking them. Interstitial cystitis, overactive bladder, and vaginal infections can all produce symptoms that feel like a UTI but won’t respond to antibiotics. The initial assessment involves a detailed history and physical examination, followed by urine analysis and a urine culture with sensitivity testing to confirm the diagnosis and guide treatment choices.1PubMed Central. Guidelines for the diagnosis and management of recurrent urinary tract infection in women That culture matters more than people realize. Knowing exactly which bacteria are present and which antibiotics they respond to prevents wasted courses of the wrong drug and slows the development of resistance.
Your urologist will also ask about things that might seem unrelated: what kind of contraception you use, how much water you drink, whether infections tend to follow sexual activity, and whether you’ve gone through menopause. These details directly shape the treatment plan.
Imaging and Cystoscopy
Not everyone with recurrent UTIs needs imaging or a camera in their bladder, and the evidence suggests that most of the time these tests come back normal. But they serve as a safety net to catch the uncommon structural problem that’s fueling the cycle.
Ultrasound is often the first imaging step. It can pick up kidney stones, significant post-void residual urine (a sign the bladder isn’t emptying properly), or anatomical abnormalities. One review noted that reasonable indications for ultrasound include recurrent non-coital UTIs, persistent blood in the urine, signs of kidney involvement, or evidence of reduced kidney function.2European Society of Radiology. Recurrent urinary tract infections: role of ultrasound for detecting causes For more complicated cases, CT urography or MR urography are considered appropriate, particularly for women who don’t respond to standard therapy, develop frequent reinfections, or have known underlying risk factors.3Journal of the American College of Radiology. ACR Appropriateness Criteria Recurrent Lower Urinary Tract Infections in Women
Cystoscopy, where a thin camera is inserted into the bladder, is used more selectively. Studies consistently find that it turns up significant abnormalities in only a small fraction of patients. One study of women with recurrent UTIs found significant cystoscopy findings in about 8% of cases, including urethral strictures, bladder stones, and a bladder diverticulum.4PubMed. Cystoscopy in women with recurrent urinary tract infection Another found significant clinical findings in roughly 5.5% of patients, with only about 4% being findings that imaging had missed entirely.5PubMed. Diagnostic yield of cystoscopy in the evaluation of recurrent urinary tract infection in women When imaging is normal, cystoscopy is also normal about 94% of the time. So if your imaging looks clean and you have no red-flag symptoms like blood in the urine, your urologist may reasonably skip cystoscopy. But when it does catch something, the finding can change the entire treatment approach.
Why the Infections Keep Coming Back
Understanding why recurrent UTIs happen helps explain the logic behind the treatments a urologist will offer. Bacteria, most commonly E. coli, don’t just sit on the bladder surface waiting to be flushed out. They can invade the cells lining the urinary tract, rapidly multiply inside them, and form intracellular communities that are shielded from both the immune system and antibiotics.6PubMed Central. The Critical Role of Intracellular Bacterial Communities in Uncomplicated Recurrent Urinary Cystitis Some bacteria form quiescent reservoirs that can lie dormant and re-emerge weeks or months later, causing what appears to be a brand-new infection but is really the same one coming back.
Bacteria also protect themselves by forming biofilms, which are structured communities encased in a protective matrix that makes them far harder to kill with standard antibiotic courses.7PubMed Central. Biofilm Lifestyle in Recurrent Urinary Tract Infections This is a key reason why a urologist’s treatment plan often goes beyond simply prescribing another round of antibiotics. Killing the free-floating bacteria is the easy part. Dislodging the ones hiding inside cells or encased in biofilm is the harder challenge, and it explains the interest in bladder instillations, electrofulguration, and other approaches designed to reach bacteria where oral antibiotics can’t.
Behavioral Changes and Water Intake
Before reaching for any prescription, a urologist will discuss lifestyle modifications. The 2025 American Urological Association guideline highlights two changes with actual evidence behind them: switching away from barrier contraceptives or spermicidal products if you use them, and drinking more water if your intake is low. Increasing water intake was associated with far fewer UTI episodes over 12 months and a longer gap between infections.8American Urological Association. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025)
The same guideline is refreshingly blunt about what doesn’t work. Case-control studies have shown that many commonly held hygiene beliefs, including front-to-back wiping, pre- and post-coital voiding, avoiding hot tubs, tampon use, and douching, do not play a role in preventing recurrent UTIs.8American Urological Association. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025) These are deeply entrenched pieces of advice, and hearing from a urologist that the evidence doesn’t support them can be both surprising and liberating.
Vaginal Estrogen for Postmenopausal Women
If you’re postmenopausal and dealing with recurrent UTIs, vaginal estrogen is one of the most effective non-antibiotic tools available. After menopause, declining estrogen levels thin the vaginal and urethral tissues and shift the local bacterial environment in ways that favor UTI-causing organisms. Topical estrogen reverses those changes.
A meta-analysis of randomized controlled trials found that vaginal estrogen had a protective effect, with a pooled risk estimate of 0.4, meaning roughly a 60% reduction in infection risk compared to controls.9F&S Reviews. Vaginal estrogen and the prevention of recurrent urinary tract infection in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials A large observational study found that UTI frequency dropped from about 3.9 per year before starting vaginal estrogen to 1.8 per year afterward, a reduction of over 50%.10American Journal of Obstetrics & Gynecology. Vaginal estrogen for recurrent urinary tract infection in postmenopausal women About a third of patients had no UTIs at all in the year after starting treatment. These are strong numbers for any prevention strategy, and vaginal estrogen carries minimal systemic absorption, making it a different proposition from oral hormone therapy. Your urologist may prescribe it directly or coordinate with your gynecologist.
Antibiotic Prophylaxis
When behavioral changes and non-antibiotic strategies aren’t enough, a urologist will discuss antibiotic prophylaxis. This isn’t the same as treating each infection as it comes; it’s a low-dose, long-term strategy designed to keep bacteria from gaining a foothold.
Clinical guidelines recommend continuous low-dose antibiotic prophylaxis for six to twelve months for women with a history of recurrent UTIs. For women whose infections are clearly tied to sexual activity, post-coital prophylaxis (a single low dose taken after intercourse) is offered as an alternative.1PubMed Central. Guidelines for the diagnosis and management of recurrent urinary tract infection in women Common choices include nitrofurantoin and trimethoprim-sulfamethoxazole at sub-therapeutic doses. The goal is prevention, not treatment of active infection, so the doses are much lower than what you’d take during a full course.
There are legitimate concerns about long-term antibiotic use and its effects on the gut. Research in children on low-dose prophylaxis found that gut microbiota diversity initially crashed during treatment for a febrile UTI but recovered within one to two months, and the diversity was maintained throughout the prophylaxis period.11The Journal of Urology. Impact of Long-Term Low Dose Antibiotic Prophylaxis on Gut Microbiota in Children That’s somewhat reassuring, but the study also found shifts in the types of bacteria present, with fewer of the Enterobacteriales that include many UTI-causing species. The tradeoff between preventing infections and altering your microbiome is real, and it’s part of why urologists prefer to try non-antibiotic options first.
D-Mannose and Other Supplements
Many patients arrive at the urologist’s office already taking D-mannose, a sugar supplement marketed for UTI prevention. The theory is that D-mannose coats the bladder lining and prevents E. coli from sticking. The reality is more disappointing. A randomized clinical trial found that daily D-mannose did not reduce the proportion of women who experienced a subsequent UTI and concluded it should not be recommended for prevention.12JAMA Internal Medicine. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial A Cochrane systematic review reached the same conclusion, finding very low certainty evidence and essentially no basis to support or refute D-mannose for preventing or treating UTIs.13PubMed Central. D‐mannose for preventing and treating urinary tract infections Your urologist will likely tell you not to rely on it.
Methenamine hippurate is a different story. It’s an older urinary antiseptic that works by releasing formaldehyde in acidic urine. Animal research has shown it improves bladder barrier function and reduces permeability in aged bladders.14PubMed Central. The impact of methenamine hippurate treatment on bladder barrier function and inflammation in aged mice and women with urinary tract infections It has been gaining renewed interest as a non-antibiotic prophylactic option, and some urologists now offer it as an alternative or complement to low-dose antibiotics.
Intravesical Instillation Therapy
For patients who fail standard prophylaxis, urologists can deliver treatments directly into the bladder through a catheter. This approach bypasses the gut entirely, avoids systemic side effects, and puts the medication exactly where the infection lives.
Two main categories are used. The first is intravesical antibiotics, most commonly aminoglycosides like gentamicin. A systematic review and meta-analysis found that aminoglycoside bladder instillations produced a dramatic reduction in UTI recurrence, with consistent benefit across different patient populations. Blood levels of the antibiotic were undetectable where measured, and side effects were mild and infrequent.15PubMed Central. Intravesical therapy for recurrent urinary tract infection: a systematic review and meta-analysis
The second category involves glycosaminoglycan (GAG) replenishment therapy, using substances like hyaluronic acid and chondroitin sulfate to rebuild the protective lining of the bladder. A randomized study found that patients receiving hyaluronic acid and chondroitin sulfate instillations had significantly fewer cystitis recurrences and improved symptoms across every measured outcome compared to controls at 12 months.16PubMed. Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study The idea is that a damaged bladder lining lets bacteria attach and invade more easily, and restoring that lining raises the barrier against new infections. Both GAG and antibiotic instillations significantly reduce UTI recurrence and improve symptoms like pain and urinary urgency.17PubMed Central. Intravesical Therapies for Recurrent Urinary Tract Infections: A Systematic Review
Electrofulguration for Chronic Bladder Lesions
During cystoscopy, some women with stubborn recurrent UTIs are found to have a condition called vesicular cystitis, where small fluid-filled lesions dot the bladder wall. These lesions are thought to harbor bacteria within the tissue. Electrofulguration is a procedure where the urologist cauterizes these lesions using electrical current, typically done as an outpatient procedure under anesthesia.
The results are surprisingly good for such a targeted intervention. One study reported that more than 80% of women experienced long-term cure or improvement in their UTIs after electrofulguration.18PubMed. Electrofulguration in the advanced management of antibiotic-refractory recurrent urinary tract infections in women Midterm follow-up data showed that the three-year UTI-free survival from needing a repeat procedure was about 71%, and over two-thirds of women didn’t need a second fulguration or daily antibiotic prophylaxis after the initial treatment.19PubMed. Midterm Follow-up of Electrofulguration for Vesicular Cystitis in Women With Recurrent Urinary Tract Infections This is a relatively new approach in the recurrent UTI toolkit and isn’t offered everywhere, but for women with antibiotic-refractory infections and visible bladder lesions, it can be a turning point.
Vaccines and Immunotherapy
Perhaps the most forward-looking tool in the urologist’s arsenal is immunotherapy. MV140 is a sublingual bacterial vaccine (a few drops under the tongue daily for three months) designed to train the immune system to better recognize and fight common UTI-causing bacteria. The first North American study found that during the nine months after vaccination, the UTI-free rate was about 41%, and the overall infection rate dropped by roughly 75% compared to the year before vaccination.20PubMed Central. MV140 sublingual vaccine reduces recurrent urinary tract infection in women Multiple studies have shown it safely reduces UTI risk, lowers antibiotic use, and improves quality of life.21PubMed Central. An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women
A broader meta-analysis of bacterial vaccines for recurrent UTIs found that vaccinated patients were about 1.5 times more likely to remain UTI-free over 6 to 12 months compared to placebo, though the evidence base is still limited and the confidence intervals wide.22PubMed. Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-analysis Availability varies by country, and regulatory approval is still pending in some regions. But immunotherapy represents a genuine shift in philosophy: instead of killing bacteria after they arrive, you’re priming the body’s own defenses to prevent colonization in the first place.
Recurrent UTIs in Men
Most of the recurrent UTI conversation and research centers on women, but men deal with them too, and the urological workup is different. In men, recurrent UTIs are frequently tied to chronic bacterial prostatitis, where the prostate itself serves as a reservoir of infection. Effective treatment requires antibiotics that penetrate prostate tissue, and the courses are much longer: typically four weeks for an acute infection and six to twelve weeks for chronic bacterial prostatitis.23PubMed. Prostatitis and urinary tract infection in men: what’s new; what’s true? For men with persistent symptoms or recurrent positive cultures, long-term suppressive antibiotic therapy may be necessary. A urologist evaluating a man with recurrent UTIs will focus heavily on prostate assessment, flow studies, and post-void residual measurement to identify obstruction from an enlarged prostate or other structural issues.
Neurogenic Bladder and Catheter Users
People who use intermittent catheterization because of a neurogenic bladder face an especially high risk of recurrent UTIs. The repeated passage of a catheter introduces bacteria, and impaired bladder emptying creates a hospitable environment for bacterial growth. Risk factors include older age, higher spinal cord lesion level, longer duration of neurogenic bladder, vesicoureteral reflux, increased bladder wall thickness, and low bladder compliance.24PubMed. Risk Factors for Recurrent Urinary Tract Infection in Children With Neurogenic Bladder Following Clean Intermittent Catheterization
For these patients, intravesical therapies become especially relevant because oral antibiotics often fail and resistance builds quickly. Gentamicin bladder instillations have been used as both therapy and prophylaxis in catheter-dependent patients.25PubMed Central. Intravesical Gentamicin: An Option for Therapy and Prophylaxis against Recurrent UTIs and Resistant Bacteria in Neurogenic Bladder Patients on Intermittent Catheterization Povidone-iodine bladder irrigation has shown striking results in this population, with one study reporting a greater than 99% reduction in symptomatic UTI rates, emergency visits, and hospitalizations, along with a significant decrease in multidrug-resistant organisms.26PubMed. Bladder irrigation with povidone-iodine prevent recurrent urinary tract infections in neurogenic bladder patients on clean intermittent catheterization These are dramatic numbers from a relatively simple intervention.
Pediatric Recurrent UTIs
Children with recurrent UTIs often land in a urologist’s office because of vesicoureteral reflux (VUR), a condition where urine flows backward from the bladder toward the kidneys. VUR predisposes children to repeated infections and, more worryingly, kidney scarring. Continuous low-dose antibiotic prophylaxis remains a standard strategy for preventing UTIs in children with VUR, particularly those with higher-grade reflux.27PubMed Central. Understanding and Managing Pediatric Urinary Tract Infections in Vesicoureteral Reflux: Insights Into Pathophysiology and Care Some children with voiding dysfunction (the bladder and pelvic floor muscles not coordinating properly) benefit from uroflowmetry testing and biofeedback training to improve their voiding patterns.28PubMed Central. Dysfunctional voiding: the importance of non-invasive urodynamics in diagnosis and treatment The urologist’s approach in children is more conservative overall, focusing on preventing kidney damage while the child grows and, in many cases, outgrows the reflux.
The Psychological and Practical Toll
One thing that often gets overlooked in clinical discussions is how much recurrent UTIs affect daily life. Research into the psychosocial burden has documented reduced quality of intimate and social relationships, lower self-esteem, and diminished capacity for work. Across multiple countries, patients took roughly three days of sick leave per year due to UTIs and experienced activity limitations on about 3.5 days annually. The average number of doctor visits was about 2.8 per year, ranging from under 2 to nearly 4 depending on the country.29PubMed Central. Psychosocial burden of recurrent uncomplicated urinary tract infections These numbers understate the real burden, because they don’t capture the anxiety between infections, the constant vigilance around triggers, or the frustration of being told by previous providers to “just drink more cranberry juice.” A urologist who specializes in recurrent UTIs understands this burden and has a toolbox deep enough to move beyond the advice you’ve already tried.